Literature DB >> 15207344

The expression of PEA-15 (phosphoprotein enriched in astrocytes of 15 kDa) defines subpopulations of astrocytes and neurons throughout the adult mouse brain.

A Sharif1, F Renault, F Beuvon, R Castellanos, B Canton, L Barbeito, M P Junier, H Chneiweiss.   

Abstract

Phosphoprotein enriched in astrocytes of 15 kDa (PEA-15) is an abundant phosphoprotein in primary cultures of mouse brain astrocytes. Its capability to interact with members of the apoptotic and mitogen activated protein (MAP) kinase cascades endows PEA-15 with anti-apoptotic and anti-proliferative properties. We analyzed the in vivo cellular sources of PEA-15 in the normal adult mouse brain using a novel polyclonal antibody. Immunohistochemical assays revealed numerous PEA-15-immunoreactive cells throughout the brain of wild-type adult mice while no immunoreactive signal was observed in the brain of PEA-15 -/- mice. Cell morphology and double immunofluorescent staining showed that both astrocytes and neurons could be cellular sources of PEA-15. Closer examination revealed that in a given area only part of the astrocytes expressed the protein. The hippocampus was the most striking example of this heterogeneity, a spatial segregation restricting PEA-15 positive astrocytes to the CA1 and CA3 regions. A PEA-15 immunoreactive signal was also observed in a few cells within the subventricular zone and the rostral migratory stream. In vivo analysis of an eventual PEA-15 regulation in astrocytes was performed using a model of astrogliosis occurring along motor neurons degeneration, the transgenic mouse expressing the mutant G93A human superoxyde-dismutase-1, a model of amyotrophic lateral sclerosis. We observed a marked up-regulation of PEA-15 in reactive astrocytes that had developed throughout the ventral horn of the lumbar spinal cord of the transgenic mice. The heterogeneous cellular expression of the protein and its increased expression in pathological situations, combined with the known properties of PEA-15, suggest that PEA-15 expression is associated with a particular metabolic status of cells challenged with potentially apoptotic and/or proliferative signals. Copyright 2004 IBRO

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15207344     DOI: 10.1016/j.neuroscience.2004.02.039

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  22 in total

1.  Proteomics analyses of human optic nerve head astrocytes following biomechanical strain.

Authors:  Ronan S Rogers; Moyez Dharsee; Suzanne Ackloo; Jeremy M Sivak; John G Flanagan
Journal:  Mol Cell Proteomics       Date:  2011-11-29       Impact factor: 5.911

2.  Identification of positionally distinct astrocyte subtypes whose identities are specified by a homeodomain code.

Authors:  Christian Hochstim; Benjamin Deneen; Agnès Lukaszewicz; Qiao Zhou; David J Anderson
Journal:  Cell       Date:  2008-05-02       Impact factor: 41.582

3.  Differential Neuroproteomic and Systems Biology Analysis of Spinal Cord Injury.

Authors:  Ahmed Moghieb; Helen M Bramlett; Jyotirmoy H Das; Zhihui Yang; Tyler Selig; Richard A Yost; Michael S Wang; W Dalton Dietrich; Kevin K W Wang
Journal:  Mol Cell Proteomics       Date:  2016-05-05       Impact factor: 5.911

4.  Phosphoprotein enriched in astrocytes-15 kDa expression inhibits astrocyte migration by a protein kinase C delta-dependent mechanism.

Authors:  François Renault-Mihara; Frédéric Beuvon; Xavier Iturrioz; Brigitte Canton; Sophie De Bouard; Nadine Léonard; Shahul Mouhamad; Ariane Sharif; Joe W Ramos; Marie-Pierre Junier; Hervé Chneiweiss
Journal:  Mol Biol Cell       Date:  2006-09-20       Impact factor: 4.138

5.  Astroglial heterogeneity closely reflects the neuronal-defined anatomy of the adult murine CNS.

Authors:  Jason G Emsley; Jeffrey D Macklis
Journal:  Neuron Glia Biol       Date:  2006-08

6.  Improved grading and survival prediction of human astrocytic brain tumors by artificial neural network analysis of gene expression microarray data.

Authors:  Lawrence P Petalidis; Anastasis Oulas; Magnus Backlund; Matthew T Wayland; Lu Liu; Karen Plant; Lisa Happerfield; Tom C Freeman; Panayiota Poirazi; V Peter Collins
Journal:  Mol Cancer Ther       Date:  2008-04-29       Impact factor: 6.261

7.  Circadian expression and functional characterization of PEA-15 within the mouse suprachiasmatic nucleus.

Authors:  Kelin Wheaton; Sydney Aten; Lucas Sales Queiroz; Kyle Sullivan; John Oberdick; Kari R Hoyt; Karl Obrietan
Journal:  Eur J Neurosci       Date:  2018-02-19       Impact factor: 3.386

8.  Deletion of PEA-15 in mice is associated with specific impairments of spatial learning abilities.

Authors:  Joe W Ramos; David A Townsend; Dawn Piarulli; Stefan Kolata; Kenneth Light; Gregory Hale; Louis D Matzel
Journal:  BMC Neurosci       Date:  2009-11-16       Impact factor: 3.288

9.  Astrocytes reverted to a neural progenitor-like state with transforming growth factor alpha are sensitized to cancerous transformation.

Authors:  Christelle Dufour; Josette Cadusseau; Pascale Varlet; Anne-Laure Surena; Giselle P de Faria; Amelie Dias-Morais; Nathalie Auger; Nadine Léonard; Estelle Daudigeos; Carmela Dantas-Barbosa; Jacques Grill; Vladimir Lazar; Philippe Dessen; Gilles Vassal; Vincent Prevot; Ariane Sharif; Herve Chneiweiss; Marie-Pierre Junier
Journal:  Stem Cells       Date:  2009-10       Impact factor: 6.277

10.  Phosphoprotein enriched in astrocytes 15 kDa (PEA-15) reprograms growth factor signaling by inhibiting threonine phosphorylation of fibroblast receptor substrate 2alpha.

Authors:  Jacob R Haling; Fen Wang; Mark H Ginsberg
Journal:  Mol Biol Cell       Date:  2009-12-23       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.